Article(id=1330127262566953609, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330127189372153867, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2018.02.013, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1512316800000, receivedDateStr=2017-12-04, revisedDate=1515600000000, revisedDateStr=2018-01-11, acceptedDate=null, acceptedDateStr=null, onlineDate=1795056651965, onlineDateStr=2026-11-19, pubDate=1518192000000, pubDateStr=2018-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795056651965, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795056651965, creator=13701087609, updateTime=1795056651965, updator=13701087609, issue=Issue{id=1330127189372153867, tenantId=1146029695717560320, journalId=1319690329412173987, year='2018', volume='39', issue='2', pageStart='S9', pageEnd='144', issueExtLink='null', onlineDate='null', pubDate='1518192000000', pubDateStr='2018-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795056634514, creator='13701087609', updateTime=1795056680728, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330127383656510048, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330127189372153867, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330127383656510049, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330127189372153867, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=142, endPage=144, ext={EN=ArticleExt(id=1330127262722142858, articleId=1330127262566953609, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Advances in the drug treatment of vitiligo, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Vitiligo is a common skin depigmentation disease without effective treatment. Currently, the major treatments include drug treatment, phototherapy, bleaching, covering therapy and surgical treatment. This review describes commonly used drug therapies for vitiligo and the new drug research progress for vitiligo.
, authors=Yi-wen YANG, Lei-hong XIANG, Cheng-feng ZHANG
*, authorsList=Yi-wen YANG, Lei-hong XIANG, Cheng-feng ZHANG, authorCompany=null, correspAuthors=Cheng-feng ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330127263011549835, articleId=1330127262566953609, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=白癜风的药物治疗研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
白癜风是常见的皮肤色素脱失性疾病,目前尚无治愈方法。临床主要治疗方式有药物治疗、光疗、脱色、遮盖疗法和手术治疗。本文综述白癜风临床常用治疗药物以及新药应用评价进展,以期寻找更好的白癜风治疗方案。
, authors=杨奕雯, 项蕾红, 张成锋
*, authorsList=杨奕雯, 项蕾红, 张成锋, authorCompany=null, correspAuthors=张成锋, authorNote=
, correspAuthorsNote=
张成锋,副主任医师,研究方向:色素性皮肤病,美容性皮肤病。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=zTkJrImbCIi78pZNrxlAew==, magXml=dNqNre3nfx0trJov3VekZA==, pdfUrl=null, pdf=2rM4ciLg9Vh0l8jzg2aJsA==, pdfFileSize=1049502, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=e7aubIPSV92GduKUOQvVTA==, mapNumber=null, fund=null)}, authors=[Author(id=1330127263384842896, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330127263535837842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, authorId=1330127263384842896, language=EN, stringName=Yi-wen YANG, firstName=Yi-wen, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127263619723923, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, authorId=1330127263384842896, language=CN, stringName=杨奕雯, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属华山医院皮肤科,上海 200040, bio={"content":"
杨奕雯,硕士研究生,研究方向:色素性皮肤病。
"}, bioImg=null, bioContent=
杨奕雯,硕士研究生,研究方向:色素性皮肤病。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127263279985292, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, xref=null, ext=[AuthorCompanyExt(id=1330127263288373901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, companyId=1330127263279985292, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China), AuthorCompanyExt(id=1330127263296762510, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, companyId=1330127263279985292, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属华山医院皮肤科,上海 200040)])]), Author(id=1330127263678444181, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330127263762330263, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, authorId=1330127263678444181, language=EN, stringName=Lei-hong XIANG, firstName=Lei-hong, middleName=null, lastName=XIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127263825244824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, authorId=1330127263678444181, language=CN, stringName=项蕾红, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属华山医院皮肤科,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127263279985292, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, xref=null, ext=[AuthorCompanyExt(id=1330127263288373901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, companyId=1330127263279985292, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China), AuthorCompanyExt(id=1330127263296762510, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, companyId=1330127263279985292, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属华山医院皮肤科,上海 200040)])]), Author(id=1330127263904936602, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330127263976239772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, authorId=1330127263904936602, language=EN, stringName=Cheng-feng ZHANG, firstName=Cheng-feng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127264060125853, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, authorId=1330127263904936602, language=CN, stringName=张成锋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=复旦大学附属华山医院皮肤科,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127263279985292, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, xref=null, ext=[AuthorCompanyExt(id=1330127263288373901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, companyId=1330127263279985292, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China), AuthorCompanyExt(id=1330127263296762510, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, companyId=1330127263279985292, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属华山医院皮肤科,上海 200040)])])], keywords=[Keyword(id=1330127264148206238, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, language=EN, orderNo=1, keyword=vitiligo), Keyword(id=1330127264215315103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, language=EN, orderNo=2, keyword=drug treatment), Keyword(id=1330127264282423968, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, language=EN, orderNo=3, keyword=application evaluation), Keyword(id=1330127264349532833, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, language=CN, orderNo=1, keyword=白癜风), Keyword(id=1330127264412447394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, language=CN, orderNo=2, keyword=药物治疗), Keyword(id=1330127264479556259, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, language=CN, orderNo=3, keyword=应用评价)], refs=[Reference(id=1330127266228581029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Ezzedine K, Eleftheriadou V, Whitton M,
et al. Vitiligo[J]. Lancet, 2015, 386(9988): 74-84., articleTitle=null, refAbstract=null), Reference(id=1330127266304078502, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Taieb A, Alomar A, Bohm M,
et al. Guidelines for the management of vitiligo: the European dermatology forum consensus[J]. Br J Dermatol, 2013, 168(1): 5-19., articleTitle=null, refAbstract=null), Reference(id=1330127266438296231, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Sassi F, Cazzaniga S, Tessari G,
et al. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck[J]. Br J Dermatol, 2008, 159(5): 1186-1191., articleTitle=null, refAbstract=null), Reference(id=1330127266555736744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识(2014版)[J]. 中华皮肤科杂志, 2014, 47(1): 69-71., articleTitle=null, refAbstract=null), Reference(id=1330127266631234217, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Jang YH, Jung SE, Shin J,
et al. Triple combination of systemic corticosteroids, excimer laser, and topical tacrolimus in the treatment of recently developed localized vitiligo[J]. Ann Dermatol, 2015, 27(1): 104-107., articleTitle=null, refAbstract=null), Reference(id=1330127266702537386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Niwa Y, Terashima T, Sumi H. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin[J]. Br J Dermatol, 2003, 149(5): 960-967., articleTitle=null, refAbstract=null), Reference(id=1330127266778034859, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Becker JC, Houben R, Vetter CS,
et al. The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report[J]. BMC Cancer, 2006, 6(1): 7-7., articleTitle=null, refAbstract=null), Reference(id=1330127266853532332, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Mikhail M, Wolchok J, Goldberg SM,
et al. Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus[J]. Arch Dermatol, 2008, 144(4): 560-561., articleTitle=null, refAbstract=null), Reference(id=1330127266937418413, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Rodrigues M, Ezzedine K, Hamzavi I,
et al. Current and emerging treatments for vitiligo[J]. J Am Acad Dermatol, 2017, 77(1): 17-29., articleTitle=null, refAbstract=null), Reference(id=1330127267050664622, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Goktas EO, Aydin F, Senturk N,
et al. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo[J]. J Eur Acad Dermatol Venereol, 2006, 20(5): 553-557., articleTitle=null, refAbstract=null), Reference(id=1330127267151327919, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Ermis O, Alpsoy E, Cetin L,
et al. Is the efficacy of psoralen plus ultraviolet a therapy for vitiligo enhanced by concurrent topical calcipotriol? a placebo-controlled double-blind study[J]. Br J Dermatol, 2001, 145(3): 472-475., articleTitle=null, refAbstract=null), Reference(id=1330127267226825392, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=高璐禄, 张峻岭, 刘天天, 等. 他卡西醇软膏联合308 nm激光治疗面部白癜风的疗效观察[J]. 医学理论与实践, 2017(5): 705-706., articleTitle=null, refAbstract=null), Reference(id=1330127267306517169, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=孙芳, 冯志宏, 孙丽磊. 他卡西醇软膏联合窄谱中波紫外线治疗白癜风疗效观察[J]. 中国美容医学, 2016(7): 61-62., articleTitle=null, refAbstract=null), Reference(id=1330127267390403250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Gamil H, Attwa E, Ghonemy S. Narrowband ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of generalized vitiligo[J]. Clin Exp Dermatol, 2010, 35(8): 919-921., articleTitle=null, refAbstract=null), Reference(id=1330127267478483635, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=杜金锋, 裴广德, 甄希, 等. 吡美莫司乳膏联合他卡西醇软膏治疗局限性白癜风疗效观察[J]. 实用皮肤病学杂志, 2015(5): 348-350., articleTitle=null, refAbstract=null), Reference(id=1330127267549786804, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Elgoweini M, Nour EDN. Response of vitiligo to narrowband ultraviolet B and oral antioxidants[J]. J Clin Pharmacol, 2009, 49(7): 852-855., articleTitle=null, refAbstract=null), Reference(id=1330127267616895669, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Dell'Anna ML, Mastrofrancesco A, Sala R,
et al. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial[J]. Clin Exp Dermatol, 2007, 32(6): 631-636., articleTitle=null, refAbstract=null), Reference(id=1330127267704976054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Middelkamp-Hup MA, Bos JD, Rius-Diaz F,
et al. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study[J]. J Eur Acad Dermatol Venereol, 2007, 21(7): 942-950., articleTitle=null, refAbstract=null), Reference(id=1330127267772084919, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Soliman M, Samy NA, Abo EM,
et al. Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo[J]. J Cosmet Laser Ther, 2016, 18(1): 7-11., articleTitle=null, refAbstract=null), Reference(id=1330127267864359608, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Leone G, Paro VA. Effect of an antioxydant cream versus placebo in patients with vitiligo in association with excimer laser. A pilot randomized, investigator-blinded, and half-side comparison trial[J]. G Ital Dermatol Venereol, 2015, 150(4): 461-466., articleTitle=null, refAbstract=null), Reference(id=1330127267935662777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Szczurko O, Shear N, Taddio A,
et al. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial[J]. BMC Complement Altern Med, 2011, 11: 21-29. doi: 10.1186/1472-6882-11-21., articleTitle=null, refAbstract=null), Reference(id=1330127268002771642, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo[J]. Clin Exp Dermatol, 2003, 28(3): 285-287., articleTitle=null, refAbstract=null), Reference(id=1330127268082463419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Parsad D, Kanwar A. Oral minocycline in the treatment of vitiligo-a preliminary study[J]. Dermatol Ther, 2010, 23(3): 305-307., articleTitle=null, refAbstract=null), Reference(id=1330127268170543804, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Siadat AH, Zeinali N, Iraji F,
et al. Narrow-band ultraviolet B versus oral minocycline in treatment of unstable vitiligo: a prospective comparative trial[J]. Dermatol Res Pract, 2014, 2014: 240856. doi: 10.1155/2014/240856., articleTitle=null, refAbstract=null), Reference(id=1330127268233458365, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Singh A, Kanwar AJ, Parsad D,
et al. Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris[J]. Indian J Dermatol Venereol Leprol, 2014, 80(1): 29-35., articleTitle=null, refAbstract=null), Reference(id=1330127268300567230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Kapoor R, Phiske MM, Jerajani HR. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo[J]. Br J Dermatol, 2009, 160(4): 861-863., articleTitle=null, refAbstract=null), Reference(id=1330127268359287487, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Grimes PE. Bimatoprost 0.03% solution for the treatment of nonfacial vitiligo[J]. J Drugs Dermatol, 2016, 15(6): 703-710., articleTitle=null, refAbstract=null), Reference(id=1330127268418007744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Noël M, Gagne C, Bergeron J,
et al. Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo[J]. Lipids Health Dis, 2004, 3: 7-11. doi: 10.1186/1476-511X-3-7., articleTitle=null, refAbstract=null), Reference(id=1330127268480922305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Vanderweil SG, Amano S, Ko WC,
et al. A double-blind, placebo-controlled, phase-Ⅱ clinical trial to evaluate oral simvastatin as a treatment for vitiligo[J]. J Am Acad Dermatol, 2017, 76(1): 150-151., articleTitle=null, refAbstract=null), Reference(id=1330127268543836866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Iraji F, Banihashemi SH, Faghihi G,
et al. A comparison of betamethasone valerate 0.1% cream twice daily plus oral simvastatin versus betamethasone valerate 0.1% cream alone in the treatment of vitiligo patients[J]. Adv Biomed Res, 2017, 6(1): 34-34., articleTitle=null, refAbstract=null), Reference(id=1330127268602557123, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Chang Y, Li S, Guo W,
et al. Simvastatin protects human melanocytes from H
2O
2-induced oxidative stress by activating Nrf2[J]. J Invest Dermatol, 2017, 137(6): 1286-1296., articleTitle=null, refAbstract=null), Reference(id=1330127268665471684, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Craiglow BG, King BA. Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy[J]. J Am Acad Dermatol, 2015, 151(10): 1110-1112., articleTitle=null, refAbstract=null), Reference(id=1330127268732580549, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Harris JE, Rashighi M, Nguyen N,
et al. Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)[J]. J Am Acad Dermatol, 2016, 74(2): 370-371., articleTitle=null, refAbstract=null), Reference(id=1330127268795495110, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Rothstein B, Joshipura D, Saraiya A,
et al. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib[J]. J Am Acad Acad Dermatol, 2017, 76(6): 1054-1060., articleTitle=null, refAbstract=null), Reference(id=1330127268845826759, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu LY, Strassner JP, Refat MA,
et al. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure[J]. J Am Acad Dermatol, 2017, 77(4): 675-682., articleTitle=null, refAbstract=null), Reference(id=1330127268908741320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Yu HS, Chang KL, Yu CL,
et al. Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo[J]. J Invest Dermatol, 1997, 108(4): 527-529., articleTitle=null, refAbstract=null), Reference(id=1330127270544519881, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Moretti S, Spallanzani A, Amato L,
et al. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions[J]. Pigment Cell Res, 2002, 15(2): 87-92., articleTitle=null, refAbstract=null), Reference(id=1330127270632600266, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim NH, Torchia D, Rouhani P,
et al. Tumor necrosis factor-alpha in vitiligo: direct correlation between tissue levels and clinical parameters[J]. Cutan Ocul Toxicol, 2011, 30(3): 225-227., articleTitle=null, refAbstract=null), Reference(id=1330127270695514827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Alghamdi KM, Khurrum H, Taieb A,
et al. Treatment of generalized vitiligo with anti-TNF-alpha agents[J]. J Drugs Dermatol, 2012, 11(4): 534-539., articleTitle=null, refAbstract=null), Reference(id=1330127270771012300, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Rigopoulos D, Gregoriou S, Larios G,
et al. Etanercept in the treatment of vitiligo[J]. Dermatology, 2007, 215(1): 84-85., articleTitle=null, refAbstract=null), Reference(id=1330127270838121165, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Simon JA, Burgos-Vargas R. Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab[J]. Dermatology, 2008, 216(3): 234-235., articleTitle=null, refAbstract=null), Reference(id=1330127270947173070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Ramirez-Hernandez M, Marras C, Martinez-Escribano JA. Infliximab-induced vitiligo[J]. Dermatology, 2005, 210(1): 79-80., articleTitle=null, refAbstract=null), Reference(id=1330127271039447759, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Carvalho CL, Ortigosa LC. Segmental vitiligo after infliximab use for rheumatoid arthritis-a case report[J]. An Bras Dermatol, 2014, 89(1): 154-156., articleTitle=null, refAbstract=null), Reference(id=1330127271102362320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Ismail WA, Al-Enzy SA, Alsurayei SA,
et al. Vitiligo in a patient receiving infliximab for refractory ulcerative colitis[J]. Arab J Gastroenterol, 2011, 12(2): 109-111., articleTitle=null, refAbstract=null), Reference(id=1330127271198831313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Lahita RG, Vernace MA. Vasculitis, vitiligo, thyroiditis, and altered hormone levels after anti-tumor necrosis factor therapy[J]. J Rheumatol, 2011, 38(3): 579-580., articleTitle=null, refAbstract=null), Reference(id=1330127271261745874, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Mattox AR, Chappell JA, Hurley MY. New-onset vitiligo during long-term, stable infliximab treatment of pityriasis rubra pilaris[J]. J Drugs Drtmatol, 2013, 12(2): 217-219., articleTitle=null, refAbstract=null), Reference(id=1330127271328854740, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Toussirot E, Salard D, Algros MP,
et al. Occurrence of vitiligo in a patient with ankylosing spondylitis receiving adalimumab][J]. Ann Dermatol Venereol, 2013, 140(12): 801-802., articleTitle=null, refAbstract=null), Reference(id=1330127271416935125, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Maruthappu T, Leandro M, Morris SD. Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab[J]. Dermatol Ther, 2013, 26(4): 370-372., articleTitle=null, refAbstract=null), Reference(id=1330127271479849686, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Posada C, Florez A, Batalla A,
et al. Vitiligo during treatment of crohn's disease with adalimumab: adverse effect or co-occurrence?[J]. Case Rep Dermatol, 2011, 3(1): 28-31., articleTitle=null, refAbstract=null), Reference(id=1330127271555347159, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=Mery-Bossard L, Bagny K, Chaby G,
et al. New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases[J]. J Eur Acad Dermatol Venereol, 2017, 31(1): 181-186., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330127266127917732, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, awardId=81573064; 81472901, language=CN, fundingSource=国家自然科学基金面上项目(81573064; 81472901), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330127263279985292, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, xref=null, ext=[AuthorCompanyExt(id=1330127263288373901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, companyId=1330127263279985292, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China), AuthorCompanyExt(id=1330127263296762510, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127262566953609, companyId=1330127263279985292, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属华山医院皮肤科,上海 200040)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.02.013, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.02.013, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2018.02.013, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2018.02.013, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1518192000000, fullTextJson=null, articleText=null, reference=null)